We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
346 hedge funds and large institutions have $4.07B invested in ADMA Biologics in 2025 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 127 increasing their positions, 113 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
312% more call options, than puts
Call options by funds: $67.2M | Put options by funds: $16.3M
81% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 37
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
16% more capital invested
Capital invested by funds: $3.5B → $4.07B (+$573M)
12% more repeat investments, than reductions
Existing positions increased: 127 | Existing positions reduced: 113
8% more funds holding
Funds holding: 321 → 346 (+25)
0.46% more ownership
Funds ownership: 86.31% → 86.78% (+0.46%)
Holders
346
Holders Change
+25
Holders Change %
+7.79%
% of All Funds
4.64%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.08%
New
67
Increased
127
Reduced
113
Closed
37
Calls
$67.2M
Puts
$16.3M
Net Calls
+$50.9M
Net Calls Change
+$22.8M
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$31.4M |
| 2 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$28.9M |
| 3 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$27.7M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$27.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$27.2M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$59.3M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$28.5M |
| 3 |
D.E. Shaw & Co
New York
|
-$26.7M |
| 4 |
ACM
Altium Capital Management
New York
|
-$23.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$23.5M |
